• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的气道炎症:与哮喘的比较。

Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.

作者信息

Sutherland E Rand, Martin Richard J

机构信息

Department of Medicine, National Jewish Medical and Research Center and the University of Colorado Health Sciences Center, Denver, Colo, USA.

出版信息

J Allergy Clin Immunol. 2003 Nov;112(5):819-27; quiz 828. doi: 10.1016/S0091.

DOI:10.1016/S0091
PMID:14610463
Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive syndrome of expiratory airflow limitation caused by chronic inflammation of the airways and lung parenchyma. The airway inflammatory response in COPD is initiated by smoking in the overwhelming majority of cases, and chronic exposure to cigarette smoke initiates a series of events that causes damage to central airways, peripheral airways, and terminal airspaces, leading to physiologic and clinical abnormalities. Although COPD shares some clinical features with asthma, another prevalent airway inflammatory disease, there are distinct differences in the phenotypic characteristics of airway inflammation between COPD and asthma. The eosinophil is the most prominent inflammatory cell in asthma, with mast cells, lymphocytes, and macrophages playing important but less prominent roles. In COPD the cellular composition of the airway inflammatory infiltrate differs, with neutrophils, macrophages, and lymphocytes assuming prominence and the eosinophil playing a minor role, except in the setting of exacerbations. The contrasting inflammatory phenotypes of asthma and COPD have important implications for clinical and physiologic manifestations of disease, as well as for therapy.

摘要

慢性阻塞性肺疾病(COPD)是一种由气道和肺实质的慢性炎症引起的进行性呼气气流受限综合征。在绝大多数情况下,COPD中的气道炎症反应由吸烟引发,长期接触香烟烟雾会引发一系列事件,导致中央气道、外周气道和终末气腔受损,进而导致生理和临床异常。尽管COPD与另一种常见的气道炎症性疾病哮喘有一些临床特征相同,但COPD和哮喘在气道炎症的表型特征上存在明显差异。嗜酸性粒细胞是哮喘中最突出的炎症细胞,肥大细胞、淋巴细胞和巨噬细胞也发挥重要作用,但不那么突出。在COPD中,气道炎症浸润的细胞组成有所不同,中性粒细胞、巨噬细胞和淋巴细胞占主导地位,嗜酸性粒细胞起次要作用,除非在病情加重的情况下。哮喘和COPD截然不同的炎症表型对疾病的临床和生理表现以及治疗都有重要影响。

相似文献

1
Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.慢性阻塞性肺疾病中的气道炎症:与哮喘的比较。
J Allergy Clin Immunol. 2003 Nov;112(5):819-27; quiz 828. doi: 10.1016/S0091.
2
Outpatient treatment of chronic obstructive pulmonary disease: comparisons with asthma.慢性阻塞性肺疾病的门诊治疗:与哮喘的比较。
J Allergy Clin Immunol. 2004 Oct;114(4):715-24; quiz 725. doi: 10.1016/j.jaci.2004.07.044.
3
Chronic obstructive pulmonary disease in a new concept.慢性阻塞性肺疾病是一个新的概念。
Rom J Morphol Embryol. 2007;48(3):207-14.
4
[Pathology of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病的病理学]
Ann Ist Super Sanita. 2003;39(4):507-17.
5
Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.白细胞介素-9作为哮喘和慢性阻塞性气道疾病的潜在治疗靶点。
Drug News Perspect. 2005 Dec;18(10):615-21. doi: 10.1358/dnp.2005.18.10.959575.
6
Pathogenesis of COPD.慢性阻塞性肺疾病的发病机制
Semin Respir Crit Care Med. 2005 Apr;26(2):142-53. doi: 10.1055/s-2005-869535.
7
Airway inflammation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道炎症。
Curr Opin Pulm Med. 2010 Mar;16(2):89-96. doi: 10.1097/MCP.0b013e3283341ba0.
8
Remodeling in asthma and COPD--differences and similarities.哮喘和慢性阻塞性肺疾病中的重塑——差异与相似之处
Clin Respir J. 2010 May;4 Suppl 1:20-7. doi: 10.1111/j.1752-699X.2010.00193.x.
9
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
10
The overlap syndrome of asthma and COPD: what are its features and how important is it?哮喘与慢性阻塞性肺疾病的重叠综合征:其特征有哪些以及重要性如何?
Thorax. 2009 Aug;64(8):728-35. doi: 10.1136/thx.2008.108027.

引用本文的文献

1
Airway remodeling in chronic obstructive pulmonary disease: characteristics and opportunities.慢性阻塞性肺疾病中的气道重塑:特征与机遇
Front Med (Lausanne). 2025 Jul 28;12:1556868. doi: 10.3389/fmed.2025.1556868. eCollection 2025.
2
Association Between the Non-High-Density Lipoprotein Cholesterol-to-High-Density Lipoprotein Cholesterol Ratio (NHHR) and Mortality in Patients with COPD: Evidence From the NHANES 1999-2018.慢性阻塞性肺疾病(COPD)患者非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与死亡率之间的关联:来自1999 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Int J Chron Obstruct Pulmon Dis. 2025 Mar 28;20:857-868. doi: 10.2147/COPD.S508481. eCollection 2025.
3
Bronchoalveolar Lavage Fluid from Chronic Obstructive Pulmonary Disease Patients Increases Neutrophil Chemotaxis Measured by a Microfluidic Platform.
慢性阻塞性肺疾病患者的支气管肺泡灌洗液可增强通过微流控平台测量的中性粒细胞趋化性。
Micromachines (Basel). 2023 Sep 6;14(9):1740. doi: 10.3390/mi14091740.
4
Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.哮喘-慢性阻塞性肺疾病重叠(ACO)患者肺部气道炎症变化:支气管镜下经支气管活检研究。
Respir Res. 2023 Sep 12;24(1):221. doi: 10.1186/s12931-023-02527-x.
5
Inter-relationships among neutrophilic inflammation, air trapping and future exacerbation in COPD: an analysis of ECOPD study.中性粒细胞炎症、空气潴留与 COPD 未来加重的相互关系:ECOPD 研究分析。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001597.
6
How does cigarette smoking affect airway remodeling in asthmatics?吸烟如何影响哮喘患者的气道重塑?
Tob Induc Dis. 2023 Jan 27;21:13. doi: 10.18332/tid/156047. eCollection 2023.
7
High-Density Lipoproteins: A Role in Inflammation in COPD.高密度脂蛋白:在 COPD 中的炎症作用。
Int J Mol Sci. 2022 Jul 23;23(15):8128. doi: 10.3390/ijms23158128.
8
Giant compressive emphysema: a rare complication of COVID-19.巨大压迫性肺气肿:COVID-19 的罕见并发症。
BMC Infect Dis. 2021 Dec 30;21(1):1283. doi: 10.1186/s12879-021-07006-6.
9
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.简要报告:吸入性皮质类固醇的使用与晚期癌症患者检查点抑制剂性肺炎的风险。
Cancer Immunol Immunother. 2020 Nov;69(11):2403-2408. doi: 10.1007/s00262-020-02674-w. Epub 2020 Jul 29.
10
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.获益:布地奈德在阻塞性气道疾病中的风险特征。
Drugs. 2019 Nov;79(16):1757-1775. doi: 10.1007/s40265-019-01198-7.